Exagen Diagnostics Inc (Exagen) is a life sciences company that helps patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. The company’s products include Avise CTD, Avise Infliximab and Avise Adalimumab, Avise SLE Prognostic, Avise HCQ, Avise MTX. Exagen’s products are used for therapeutic drug monitoring of hydroxychloroquine in whole blood and methotrexate polyglutamates, risk assessment testing, anti-TNF monitoring to individualize therapy and optimize dosing, and others. The company serves physicians and patients. It operates in Albuquerque, and New Mexico. Exagen is headquartered in Vista, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Exagen Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Exagen Diagnostics Inc Company Overview
- Exagen Diagnostics Inc Company Snapshot
- Exagen Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Exagen Diagnostics Inc - Pipeline Analysis Overview
- Exagen Diagnostics Inc - Key Facts
- Exagen Diagnostics Inc - Major Products and Services
- Exagen Diagnostics Inc Pipeline Products by Development Stage
- Exagen Diagnostics Inc Pipeline Products Overview
- AVISE RA Dx
- AVISE RA Dx Product Overview
- AVISE RA Monitoring Device
- AVISE RA Monitoring Device Product Overview
- AVISE RA Prognostic Device
- AVISE RA Prognostic Device Product Overview
- AVISE RADR
- AVISE RADR Product Overview
- AVISE SLE Monitor 2.0
- AVISE SLE Monitor 2.0 Product Overview
- AVISE SLE Monitor Plus
- AVISE SLE Monitor Plus Product Overview
- AVISE Thrombosis
- AVISE Thrombosis Product Overview
- Fibromyalgia Diagnostic Test
- Fibromyalgia Diagnostic Test Product Overview
- Exagen Diagnostics Inc - Key Competitors
- Exagen Diagnostics Inc - Key Employees
- Exagen Diagnostics Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Exagen Diagnostics Inc, Recent Developments
- Dec 12, 2024: Exagen Achieves Key Milestone with 1,000,000th Patient Tested by AVISE CTD
- Nov 14, 2024: Exagen Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE CTD Platform
- Oct 21, 2024: Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
- Sep 20, 2022: Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting
- Sep 20, 2022: Exagen announces acceptance of multiple abstracts at ACR 2022 Annual Meeting
- Jul 05, 2022: Exagen releases largest comparative utility study in lupus diagnostics confirming AVISE Lupus delivers unparalleled utility
- Jun 09, 2022: Exagen expands coverage with MediNcrease
- May 16, 2022: Exagen expands coverage with Alivio Health, partnering to provide more accurate diagnostic testing with AVISE CTD and AVISE Lupus
- May 11, 2022: Exagen announces new PLA code and Medicare pricing for proprietary AVISE Lupus test
- Mar 30, 2022: Exagen expands in-network access with evolutions healthcare systems
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Exagen Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Exagen Diagnostics Inc Pipeline Products by Equipment Type
- Exagen Diagnostics Inc Pipeline Products by Indication
- Exagen Diagnostics Inc, Key Facts
- Exagen Diagnostics Inc, Major Products and Services
- Exagen Diagnostics Inc Number of Pipeline Products by Development Stage
- Exagen Diagnostics Inc Pipeline Products Summary by Development Stage
- AVISE RA Dx - Product Status
- AVISE RA Dx - Product Description
- AVISE RA Monitoring Device - Product Status
- AVISE RA Monitoring Device - Product Description
- AVISE RA Prognostic Device - Product Status
- AVISE RA Prognostic Device - Product Description
- AVISE RADR - Product Status
- AVISE RADR - Product Description
- AVISE SLE Monitor 2.0 - Product Status
- AVISE SLE Monitor 2.0 - Product Description
- AVISE SLE Monitor Plus - Product Status
- AVISE SLE Monitor Plus - Product Description
- AVISE Thrombosis - Product Status
- AVISE Thrombosis - Product Description
- Fibromyalgia Diagnostic Test - Product Status
- Fibromyalgia Diagnostic Test - Product Description
- Exagen Diagnostics Inc, Key Employees
- Glossary
- Exagen Diagnostics Inc Pipeline Products by Equipment Type
- Exagen Diagnostics Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Albireo Pharma Inc
- Syntron Bioresearch Inc
- Stemline Therapeutics Inc
- ReShape Lifesciences Inc
- Bionostics Inc
- Milagen Inc
